Home - Products - Chromatin/Epigenetic - Histone Demethylase - SD-70

SD-70

CAS No. 332173-89-4

SD-70( SD70 )

Catalog No. M14117 CAS No. 332173-89-4

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

SD-70
Note

Research use only, not for human use.
Brief Description

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program.
Description

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM); represses AR transcriptional program, increases H3K9me2 levels in 293T cells; inhibits tumor growth in CWR22Rv1 prostate cancer xenograft mice model.
In Vitro

——
In Vivo

——
Synonyms

SD70
Pathway

Chromatin/Epigenetic
Target

Histone Demethylase
Recptor

Histone Demethylase
Research Area

——
Indication

——

Chemical Information

CAS Number

332173-89-4
Formula Weight

310.353
Molecular Formula

C18H18N2O3
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

N-(furan-2-yl(8-hydroxyquinolin-7-yl)methyl)isobutyramide

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Jin C, et al. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9235-40.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SAH-EZH2

EZH2/EPP interaction inhibitor (Kd = 320 nM). Suppresses EZH2 expression and H3K27 trimethylation by PCR2 complex. Arrests proliferation and induces monocyte to macrophage differentiation of MLL-AF9 leukemia cell line.
LSD1-IN-11p

LSD1-IN-11p is a reversible LSD1 inhibitor with IC50/Kd of 79/21 nM.
JQKD82

JQKD82 is a selective inhibitor of KDM5 and increases H3K4me3. JQKD82 can be used in studies about the treatment of multiple myeloma.

Sign In Join Free